Comparative Efficacy of Uterine Artery Embolization versus Laparoscopic Myomectomy in Treating Uterine Fibroids: A Propensity Score Matched Analysis

Author:

Wei Cunbao1,Sun Xingwei2,Li Shenzhi2,Bai Xuming2,Jin Yong2

Affiliation:

1. The Third People’s Hospital of Dafeng District

2. Second Affiliated Hospital of Soochow University

Abstract

Abstract Objective: The aim of this study was to comparatively analyze the therapeutic effects of uterine artery embolization (UAE) and laparoscopic myomectomy (LM) on uterine fibroids to determine which treatment method is more beneficial for patients. Materials and Methods:A retrospective study was conducted on 396 patients who underwent UAE(n=153)or LM (n=243)treatment from April 2010 to September 2019. After 1:1 propensity score matching(PSM), a comparative analysis was conducted on surgical trauma magnitude, postoperative recovery time, improvement in associated symptoms and quality of life, surgical adverse events, recurrence rates, and further interventions. Results: In PSM, 66 pairs (132 patients) were successfully matched. Both treatments significantly alleviated symptoms and enhanced quality of life. Compared to the LM group, the UAE group had less intraoperative bleeding (P<0.001), a lower rate of hemoglobin decrease (P<0.001), shorter operation, postoperative, and overall hospital stays (P<0.001), and a lower postoperative recurrence rate (P<0.05), all statistically significant. Moreover, the UAE group showed notable advantages in postoperative activities (P<0.05). However, UAE patients faced higher hospitalization costs (P<0.001). Adverse event rates (7.6% vs. 9.1%) and postoperative reintervention rates (7.6% vs. 7.6%) were relatively low and not significantly different between groups (P>0.05). Conclusion: Both UAE and LM can significantly improve patient symptoms and enhance their quality of life, and both treatment methods have low rates of adverse events and reinterventions. Compared to LM, UAE treatment for uterine fibroids presents advantages such as lesstrauma, faster recovery, and lower recurrence rate,but has higher treatment costs.

Publisher

Research Square Platform LLC

Reference21 articles.

1. Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment;Yang Q;Endocr Rev,2022

2. Uterine fibroids: assessing unmet needs from bench to bedside;Aninye IO;J Womens Health (Larchmt),2021

3. Chinese Expert Consensus on the Diagnosis and Treatment of Uterine Fibroids [J];Lang;Chin J Obstet Gynecol,2017

4. Comparison of two invasive non-surgical treatment options for uterine myomas: uterine artery embolization and magnetic resonance guided high intensity focused ultrasound-systematic review;Yerezhepbayeva M;BMC Womens Health,2022

5. Epidemiology and management of uterine fibroids;Giuliani E;Int J Gynaecol Obstet,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3